在接受达比加群治疗的中风患者中使用重组组织型纤溶酶原激活剂进行静脉溶栓治疗。 - Suppr

Suppr

超能文献

Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.

作者信息

De Smedt Ann, De Raedt Sylvie, Nieboer Koenraad, De Keyser Jacques, Brouns Raf

机构信息

Department of Neurology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, Brussels, Belgium.

出版信息

Cerebrovasc Dis. 2010;30(5):533-4. doi: 10.1159/000319886. Epub 2010 Sep 28.

DOI:10.1159/000319886

PMID:20881383

Abstract

摘要

相似文献

Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.

Cerebrovasc Dis. 2010;30(5):533-4. doi: 10.1159/000319886. Epub 2010 Sep 28.

Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.

Cerebrovasc Dis. 2012;34(3):246-7. doi: 10.1159/000342307. Epub 2012 Sep 26.

Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.

Acta Neurochir (Wien). 2012 Jan;154(1):87. doi: 10.1007/s00701-011-1196-x. Epub 2011 Oct 25.

Intravenous thrombolysis in a stroke patient taking dabigatran.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):916.e11-2. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.008. Epub 2012 May 16.

Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.

Am J Emerg Med. 2014 Nov;32(11):1435.e1-2. doi: 10.1016/j.ajem.2014.04.021. Epub 2014 Apr 18.

Intravenous thrombolysis in a stroke patient taking dabigatran.

J Stroke Cerebrovasc Dis. 2013 Aug;22(6):894. doi: 10.1016/j.jstrokecerebrovasdis.2012.06.017. Epub 2012 Aug 4.

Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1351-5. doi: 10.1016/j.jstrokecerebrovasdis.2013.11.013. Epub 2014 Jan 7.

[Successful thrombolysis without hemorrhage in a patient with cardioembolic stroke under dabigatran treatment-a case report and review of literature].

Rinsho Shinkeigaku. 2014;54(3):238-40. doi: 10.5692/clinicalneurol.54.238.

Dabigatran: a new oral anticoagulant.

J Perianesth Nurs. 2011 Dec;26(6):420-3. doi: 10.1016/j.jopan.2011.09.013.

Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):917.e5-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.05.003. Epub 2012 Jun 9.

引用本文的文献

Before, during, and after: An Argument for Safety and Improved Outcome of Thrombolysis in Acute Ischemic Stroke with Direct Oral Anticoagulant Treatment.

Ann Neurol. 2024 Nov;96(5):871-886. doi: 10.1002/ana.27058. Epub 2024 Sep 11.

Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats.

J Inflamm Res. 2020 Dec 24;13:1185-1205. doi: 10.2147/JIR.S284471. eCollection 2020.

Tissue plasminogen activator; identifying major barriers related to intravenous injection in ischemic acute cerebral infraction.

J Res Med Sci. 2017 Feb 16;22:19. doi: 10.4103/1735-1995.200318. eCollection 2017.

Newer Oral Anticoagulants: Stroke Prevention and Pitfalls.

Open Cardiovasc Med J. 2016 May 27;10:94-104. doi: 10.2174/1874192401610010094. eCollection 2016.

Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.

Neurohospitalist. 2015 Jul;5(3):110-21. doi: 10.1177/1941874415578532.

Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.

Can Fam Physician. 2014 Nov;60(11):997-1001.

Is intravenous recombinant tissue plasminogen activator (r-tPA) safe in patients on Dabigatran?

J Vasc Interv Neurol. 2014 May;7(1):21-2.

Intravenous thrombolysis in a stroke patient receiving rivaroxaban.

Cerebrovasc Dis Extra. 2013 Oct 26;3(1):153-5. doi: 10.1159/000355839. eCollection 2013.

Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies.

Neurohospitalist. 2011 Jul;1(3):138-47. doi: 10.1177/1941875211408731.

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.

Clin Res Cardiol. 2013 Jun;102(6):399-412. doi: 10.1007/s00392-013-0560-7. Epub 2013 May 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验